PHT Corporation announced that pharmaceutical, diagnostic and biotechnology senior executive Stephen J. Sullivan joined its Board of Directors. PHT is the leading provider of innovative technology systems used to collect patient-driven eData for clinical research.
PHT President, CEO and Director Philip Lee said, “It is a pleasure to welcome Steve Sullivan to the PHT Board of Directors. Steve is a proven leader in guiding and advising public, private and venture-backed companies in the clinical trial services market sector.
Help employers find you! Check out all the jobs and post your resume.
